Market research
ADO.AU AnteoTech Limited
AU AUD Basic Materials
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 46M
- P/E ratio
- Not available
- Analyst target
- 0.082
- Dividend yield
- Not available
- Beta
- 1.34
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- ISIN
- AU000000ADO8
- Market cap
- 46M
- P/E ratio
- Not available
- Analyst target
- 0.082
- Dividend yield
- Not available
- Beta
- 1.34
About
About AnteoTech Limited
AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company's products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development, and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. It also provides AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, the company offers contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
Research context
AnteoTech Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ADO.AU discussion.
5 years, 6 months ago
AnteoTech Limited is currently in a long term uptrend where the price is trading 30.4% above its 200 day moving average.
From a valuation standpoint, the stock is 59.5% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 410.7.
AnteoTech Limited's total revenue rose by 503.5% to $546K since the same quarter in the previous year.
Its net income has dropped by 32.5% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 80.7% to $-221K since the same quarter in the previous year.
Based on the above factors, AnteoTech Limited gets an overall score of 3/5.